We are live on ! Find out more
LPL Financial

LPL Financial Portfolio holdings

AUM $377B
1-Year Est. Return 19.32%
 

LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.59%
1 Year Est. Return
+19.32%
3 Year Est. Return
+55.16%
5 Year Est. Return
+57.65%
10 Year Est. Return
+189.09%
AUM
$117B
AUM Growth
+$13.1B
Cap. Flow
+$6.24B
Cap. Flow %
5.34%
Top 10 Hldgs %
16.81%
Holding
4,669
New
252
Increased
2,329
Reduced
1,746
Closed
216

Sector Composition

Rank Sector Weight
1 Technology 5.07%
2 Healthcare 3.26%
3 Financials 3.13%
4 Industrials 2.22%
5 Consumer Discretionary 2.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATIP
4401
DELISTED
ATI Physical Therapy, Inc.
ATIP
$8.39K ﹤0.01%
550
DHC
4402
Diversified Healthcare Trust
DHC
$2.15B
$8.36K ﹤0.01%
12,926
+1,337
+12% +$1.32K
TMC icon
4403
TMC The Metals Company
TMC
$1.54B
$8.29K ﹤0.01%
+10,765
New +$9.31K
BLCM
4404
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$7.58K ﹤0.01%
10,527
TMQ
4405
Trilogy Metals
TMQ
$541M
$7.32K ﹤0.01%
13,310
+166
+1% +$97
SER icon
4406
Serina Therapeutics
SER
$30M
$7.12K ﹤0.01%
367
+3
+0.8% +$63
VLTA
4407
DELISTED
Volta Inc.
VLTA
$7.11K ﹤0.01%
19,999
-3,885
-16% -$2.95K
CARM
4408
DELISTED
Carisma Therapeutics
CARM
$7.1K ﹤0.01%
583
-50
-8% -$525
CIFR icon
4409
Cipher Digital
CIFR
$9.13B
$7.1K ﹤0.01%
12,678
-2,538
-17% -$2.21K
RUBY
4410
DELISTED
Rubius Therapeutics, Inc
RUBY
$6.88K ﹤0.01%
39,307
-16,990
-30% -$4.64K
AUD
4411
DELISTED
Audacy, Inc.
AUD
$6.34K ﹤0.01%
28,172
+7,923
+39% +$2.5K
AMPX.WS icon
4412
Amprius Technologies Warrants
AMPX.WS
$395M
$5.88K ﹤0.01%
20,250
DOMA
4413
DELISTED
Doma Holdings, Inc.
DOMA
$4.61K ﹤0.01%
407
-119
-23% -$1.35K
CNVS icon
4414
Cineverse
CNVS
$56.2M
$3.9K ﹤0.01%
503
ARVL
4415
DELISTED
Arrival Ordinary Shares
ARVL
$3.77K ﹤0.01%
472
+195
+70% +$4.64K
ZOM
4416
DELISTED
Zomedica Corp.
ZOM
$3.47K ﹤0.01%
21,275
-4,283
-17% -$878
PLXP
4417
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$3.41K ﹤0.01%
20,760
-9,640
-32% -$4.04K
JAGX icon
4418
Jaguar Health
JAGX
$4.91M
0
VTGN icon
4419
VistaGen Therapeutics
VTGN
$9.89M
$3.3K ﹤0.01%
1,067
IDEX
4420
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$3.26K ﹤0.01%
159
-70
-31% -$2.03K
BIOR
4421
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$3.03K ﹤0.01%
92
+46
+100% +$3.35K
BFLY.WS
4422
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$2.86K ﹤0.01%
+11,000
New +$5.63K
YARW
4423
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$2.54K ﹤0.01%
19
HGEN
4424
DELISTED
HUMANIGEN, INC.
HGEN
$1.89K ﹤0.01%
+15,740
New +$2.27K
GMBL
4425
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$1.62K ﹤0.01%
1

Similar funds

LPL Financial's Q4 2022 Portfolio in Review

As of Q4 2022, LPL Financial held 4,669 positions worth $117B, up 13% from $104B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

LPL Financial deployed $6.24B of net new capital in Q4 2022, opening 252 new positions and adding to 2,329 existing holdings. Its largest new stake was First Trust Limited Duration Investment Grade Corporate ETF: 1,813,651 shares worth $33.9M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $363M trimmed.

  • LPL Financial's largest Q4 2022 buy was First Trust Limited Duration Investment Grade Corporate ETF: 1,813,651 shares worth $33.9M.
  • LPL Financial added most to iShares MBS ETF in Q4 2022, an estimated $272M increase.
  • LPL Financial's biggest Q4 2022 reduction was iShares US Treasury Bond ETF, cutting an estimated $363M.
  • LPL Financial fully exited iShares iBonds Dec 2022 Term Corporate ETF in Q4 2022, selling an estimated $26.9M.
  • LPL Financial's ten largest holdings make up 17% of its $117B portfolio in Q4 2022.
  • LPL Financial opened 252 new positions and closed 216 in Q4 2022.
  • LPL Financial's portfolio value rose 13% quarter-over-quarter to $117B.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.